Pharmaceutical Marketers & Agencies
Pharmaceutical marketers and agencies understand the need to link Direct-to-Consumer and patient communications campaigns with actual Rx behavior. Crossix ScoreBoard™ Reports empower pharmaceutical marketers to make marketing decisions based on objective, quantifiable Rx-based data presented in actionable, timely and cost-effective reports. Crossix analytics can benefit every brand and apply across brands, answering key questions, allowing real-time optimization of marketing budgets and calculation of ROI for each campaign.
Crossix offers an entirely new way for pharmaceutical marketers to use Rx data to design, test, measure and optimize their patient and consumer communications programs. In fact, Crossix provides consumer Rx matchback analytics to many of the largest pharmaceutical companies and brands.
Crossix analytics allows real-time optimization of marketing budgets and calculation of ROI for each campaign, with Crossix reports spanning the marketing lifecycle, including audience reach/lead acquisition, conversion, retention and planning. Solutions to measure and optimize programs ranging from direct response (DR) to general awareness and branding campaigns (GA), and multi channel, from Web to Print to TV.
For any identifiable audiences, Crossix is wired to inform, providing answers to key marketing questions – reaching the right audience? Converting net of control? Staying on therapy? Crossix partnerships help identify the relevant audiences and allow measurement of the full range of marketing possibilities, including lead ratings, co-pay card providers, doctors' office registration, online and offline publishers, internet panels, TV viewers, etc. Crossix continues to add Publisher and Media Measurement Partners, sometimes driven by specific pharma client requests, as well as independently.
Rx measurement across audiences provides holistic understanding of consumer marketing
Example
Working with a leading brand to measure its consumer campaigns across all media channels and tactics, Crossix analyzed the prescription profile and conversion of audience by media tactic. Through optimization of media spend, scaling what works and stopping or changing what does not, the brand reduced overall cost per new patient start (above control) by more than 70%. Timely, granular, ongoing Rx measurement enabled brand to shift spend to better performing creative, reach more targeted audience, optimize spend to reach targeted audience at a lower cost and increase volume of new patient starts 7-fold.
Drive more volume, more cost effectively, through optimization
Crossix has specifically replaced existing analytics vendors, after rigorous and thorough head to head benchmark testing by pharma market research groups of Crossix vs. prior analyses done by other analytics companies.
Crossix simply has a better, faster, more cost effective approach to consumer/patient matchback.
The patented technology and methodology provides unique advantages over any other solution in the marketplace. The unbiased nature of the Rx data and unique means of matching client data to Rx data provides more accurate results, more quickly, on an ongoing basis.
Learn more about our Unique Advantages, or if you are interested in more information, contact us.